News
23 December 2025
How high-content screening enables cannabinoid receptor research while avoiding controlled substance restrictions and improving assay scalability.
16 December 2025
High-content screening enables precise CB2 receptor binding analysis in preclinical research using advanced imaging, quantification, and assay tools.
11 November 2025
How fluorescent ligands offer a scalable, specific alternative to cell painting in high-content screening workflows.
28 October 2025
How to design robust high-content screening (HCS) assays, avoid artifacts and batch effects, and improve drug discovery results.
7 October 2025
Cannabinoid receptor function, brain targets, and antagonist assay strategies in drug discovery.
29 September 2025
GLP‑1 receptor agonists’ mechanisms and how fluorescent assays enhance preclinical drug discovery.
11 September 2025
Sigma receptor 1 in CNS disorders and drug discovery. Discover how targeted assays and fluorescent ligands enhance selectivity and therapeutic potential.
28 August 2025
How biotinylated fluorophores and fluorescent labeling enhance ligand binding assays by improving signal detection and specificity.
14 August 2025
How biochemical assays enhance kinase activity detection in drug discovery. Assay formats, fluorescent ligands, and pathway insights for R&D success.